共 20 条
- [1] Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200) [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (01) : 90 - 94
- [10] Michener CM, 2005, ONCOLOGY-NY, V19, P1277